Mariia Ivanova, transl. (2021) “Guideline Summary NGC (2016): Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes”, KIDNEYS, (4.18), p. 36. doi: 10.22141/2307-1257.4.18.2016.84326.